West Pharmaceutical Services Inc

Common Name

West Pharmaceutical Services

Country

United States

Sector

Healthcare

Industry

Medical Instruments & Supplies

Employees

10,600

Ticker

WST

Exchange

NEW YORK STOCK EXCHANGE, INC.

Website

www.westpharma.com

Description

West Pharmaceutical Services, Inc. is a leading provider of innovative solutions for injectable drug administration, operating in the life sciences tools and services industry. Established in 1923, th... Show more

Financial Statements of West Pharmaceutical Services

Below are the financial statements of West Pharmaceutical Services, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in billions of USD	2024	2023
Current assets	—	—
Cash and cash equivalents	0.48^a	0.85^a
Accounts receivable, net	0.55^a	0.51^a
Inventories	0.38^a	0.43^a
Other current assets	0.12^a	0.14^a
Total current assets	1.54^a	1.94^a
Assets	—	—
Property, plant and equipment	2.99^a	2.74^a
Less: accumulated depreciation and amortization	1.4^a	1.32^a
Property, plant and equipment, net	1.58^a	1.41^a
Operating lease right-of-use assets	0.1^a	0.1^a
Investments in affiliated companies	0.2^a	0.21^a
Goodwill	0.11^a	0.11^a
Intangible assets, net	0.01^a	0.02^a
Deferred income taxes	0.03^a	0.03^a
Other noncurrent assets	0.07^a	0.02^a
Total assets	3.64^a	3.83^a
Current liabilities	—	—
Notes payable and other current debt	0^a	0.13^a
Accounts payable	0.24^a	0.24^a
Accrued salaries, wages and benefits	0.07^a	0.11^a
Income taxes payable	0.03^a	0.02^a
Operating lease liabilities	0.02^a	0.02^a
Other current liabilities	0.19^a	0.16^a
Total current liabilities	0.55^a	0.67^a
Liabilities and equity	—	—
Long-term debt	0.2^a	0.07^a
Deferred income taxes	0.02^a	0.01^a
Pension and other postretirement benefits	0.03^a	0.03^a
Operating lease liabilities	0.08^a	0.08^a
Deferred compensation benefits	0.02^a	0.02^a
Other long-term liabilities	0.06^a	0.06^a
Total liabilities	0.96^a	0.95^a
Equity	—	—
Preferred stock	0^a	0^a
Common stock	0.02^a	0.02^a
Capital in excess of par value	0.02^a	0.12^a
Retained earnings	3.96^a	3.52^a
Accumulated other comprehensive loss	-0.26^a	-0.14^a
Treasury stock, at cost	-1.06^a	-0.64^a
Total equity	2.68^a	2.88^a
Total liabilities and equity	3.64^a	3.83^a

Verified Sources Behind West Pharmaceutical Services’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore West Pharmaceutical Services’s data sources below and access millions more through our Disclosure Search.

a. West Pharmaceutical Services's 10-K 2024

Trace every data point back to West Pharmaceutical Services’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

West Pharmaceutical Services Inc

Financial Statements of West Pharmaceutical Services

Verified Sources Behind West Pharmaceutical Services’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Baxter International Inc

Zimmer Biomet Holdings Inc

Bio Rad Laboratories Inc

Bio-Techne Corp

Organon & Co

Dexcom Inc